The startup has developed a sub-millimetric nanobot capable of navigating through brain tissues to diagnose and treat neuropathologies with minimal trauma. This device incorporates nanoelectronics to transmit critical data to neuroscientists, facilitating targeted interventions for neurological diseases and brain tumors.
Funding
Funding not disclosed
Founders
Product
Problem
Current neurosurgical interventions often lack the precision needed to navigate the brain's complex structures, leading to potential trauma and limited access to deep-seated pathologies. Traditional methods may also struggle with real-time data collection, hindering accurate diagnosis and treatment of neurological diseases and brain tumors.
Solution
Robeauté is developing microrobotic platform designed to enhance neurosurgical procedures through increased precision and flexibility. Their modular microrobots, smaller than a grain of rice, are engineered to navigate the brain with minimal invasiveness. Equipped with interchangeable micro-extensions, the robots can adapt to various clinical applications, including tissue sampling, targeted drug delivery, and electrode implantation. The platform aims to provide real-time data collection from deep within the brain, enabling physicians to improve diagnostic accuracy and therapeutic outcomes. By operating at a scale where adhesion forces dominate, the microrobots can move and interact with cells in a controlled manner, offering a new approach to treating neurological disorders.
Target Audience
The primary target audience includes neurosurgeons and medical professionals seeking advanced tools for precise and minimally invasive diagnosis and treatment of neuropathologies, as well as pharmaceutical and biotech companies focused on targeted drug delivery to the brain.
Features
- Sub-millimetric size allows for navigation through brain tissues with minimal invasiveness.
- Modular design with interchangeable micro-extensions for diverse applications.
- Potential for real-time data collection via integrated sensors.
- AI-driven adaptation to different medical indications.
- Custom micro-fabrication processes and micro-assembly techniques.